The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2023 | Underrepresentation of elderly patients with CLL in clinical trials
Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd, CLL Society, Inc., Chula Vista, CA, discusses the underrepresentation of elderly individuals in clinical trials, and advocates for greater inclusivity in future trials in order to provide data which is more representative of real-world patient populations. Dr Koffman also comments on how less toxic, efficacious novel agents have shifted the treatment paradigm for elderly patients. This interview took place at the 20th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
